IRMD
Iradimed Co
82.10$
-0.7%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +195.8% | +23.0% | -63.7% | +115.9% | +38.7% | -43.1% | +93.5% | -10.8% | +34.1% | +90.3% | -2.6% | |
| – | +50.2% | +10.9% | +427.1% | -15.6% | +12.4% | +7.8% | +5.1% | -52.3% | +14.1% | +6.9% | +42.6% | |
| – | +68.5% | +51.0% | +33.3% | -28.1% | +5.1% | +113.6% | -63.2% | -4.5% | +56.9% | +15.4% | +15.6% | |
| – | -166.4% | – | +176.5% | -25.2% | -25.3% | +222.7% | -50.9% | -23.5% | – | – | – | |
| – | – | +77.2% | -318.0% | – | – | – | – | – | – | – | -215.9% | |
| – | -48.1% | +384.2% | -45.9% | -67.9% | +83.6% | +31.1% | +16.5% | +152.8% | +327.0% | 0.0% | -3.0% | |
| – | -99.3% | +3,059.0% | -47.3% | – | +111.2% | -92.3% | +162.5% | -312.1% | +482.3% | +10.1% | -4.5% | |
| – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +5.3% | +3.4% | +10.0% | |
| – | -95.2% | -1,768.5% | -81.8% | -83.0% | +52.8% | +155.2% | -50.4% | – | -516.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -81.7% | -492.0% | -79.2% | – | +117.3% | -74.1% | -95.3% | -52,122.1% | +7.5% | +5.0% | +22.8% | |
| – | +41.8% | -116.7% | – | +1,895.9% | +57.3% | -57.4% | +81.1% | -133.9% | – | – | -143.5% | |
| – | +270.5% | +7.5% | -67.1% | +174.4% | +37.1% | -46.8% | +103.0% | -22.3% | -33.2% | +222.8% | -2.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.